Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
© 2020 Azadvari et al..
PURPOSE: Multiple sclerosis (MS) is the most neurologic disease among individuals of 20-45 years. About 75% of MS patients report bladder problems that have a moderate-high impact on their life. The present study aimed to translate and determine the validity and reliability of the Persian version of ABSST questionnaire.
METHODS: The standard validation process for preparing the Persian version of ABSST was performed by means of an expert committee. After a pilot study and confirming the harmonized translated form, we tested the final version of questionnaire on 40 patients with a definite diagnosis of MS symptoms, once at the baseline and another after two weeks in order to prevent recall-induced agreement. Test-retest reliability was calculated as Spearman's correlation coefficient. Also, content validity indices (CVIs), as well as internal consistency were analyzed in STATA.
RESULTS: Forty participants with a mean age of 38.8 years were included in this study. Only 20% of them were male. The Persian version achieved a good internal consistency with a Cronbach-α value of 0.91, relatively similar to the original version. The coefficients for measuring the correlation between each item score with the total score of our questionnaire were between 0.58-0.89. This value confirmed an appropriate validity for the Persian version of ABSST. Regarding test-retest reliability assessment, total Spearman`s coefficient was 0.85; with 0.84 for the severity of symptoms and 0.87 for the impact of urologic disorders on patients` social life.
CONCLUSION: The current findings proved that this accurate questionnaire could be used to investigate urinary symptoms among Persian-speaking MS patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Journal of multidisciplinary healthcare - 13(2020) vom: 01., Seite 79-83 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Azadvari, Mohaddeseh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Revised 12.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/JMDH.S236275 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM306160412 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM306160412 | ||
003 | DE-627 | ||
005 | 20231225122743.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/JMDH.S236275 |2 doi | |
028 | 5 | 2 | |a pubmed24n1020.xml |
035 | |a (DE-627)NLM306160412 | ||
035 | |a (NLM)32021237 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Azadvari, Mohaddeseh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.04.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2020 Azadvari et al. | ||
520 | |a PURPOSE: Multiple sclerosis (MS) is the most neurologic disease among individuals of 20-45 years. About 75% of MS patients report bladder problems that have a moderate-high impact on their life. The present study aimed to translate and determine the validity and reliability of the Persian version of ABSST questionnaire | ||
520 | |a METHODS: The standard validation process for preparing the Persian version of ABSST was performed by means of an expert committee. After a pilot study and confirming the harmonized translated form, we tested the final version of questionnaire on 40 patients with a definite diagnosis of MS symptoms, once at the baseline and another after two weeks in order to prevent recall-induced agreement. Test-retest reliability was calculated as Spearman's correlation coefficient. Also, content validity indices (CVIs), as well as internal consistency were analyzed in STATA | ||
520 | |a RESULTS: Forty participants with a mean age of 38.8 years were included in this study. Only 20% of them were male. The Persian version achieved a good internal consistency with a Cronbach-α value of 0.91, relatively similar to the original version. The coefficients for measuring the correlation between each item score with the total score of our questionnaire were between 0.58-0.89. This value confirmed an appropriate validity for the Persian version of ABSST. Regarding test-retest reliability assessment, total Spearman`s coefficient was 0.85; with 0.84 for the severity of symptoms and 0.87 for the impact of urologic disorders on patients` social life | ||
520 | |a CONCLUSION: The current findings proved that this accurate questionnaire could be used to investigate urinary symptoms among Persian-speaking MS patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a multiple sclerosis | |
650 | 4 | |a questionnaires | |
650 | 4 | |a reliability | |
650 | 4 | |a reliability studies | |
650 | 4 | |a urinary symptoms | |
700 | 1 | |a Naser Moghadasi, Abdorreza |e verfasserin |4 aut | |
700 | 1 | |a Azimi, Amir Reza |e verfasserin |4 aut | |
700 | 1 | |a Sharifiaghdas, Farzaneh |e verfasserin |4 aut | |
700 | 1 | |a Emami Razavi, Seyede Zahra |e verfasserin |4 aut | |
700 | 1 | |a Eskandarieh, Sharareh |e verfasserin |4 aut | |
700 | 1 | |a Hosseini, Maryam |e verfasserin |4 aut | |
700 | 1 | |a Rahimi-Dehgolan, Shahram |e verfasserin |4 aut | |
700 | 1 | |a Sahraian, Mohammad Ali |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of multidisciplinary healthcare |d 2008 |g 13(2020) vom: 01., Seite 79-83 |w (DE-627)NLM198425007 |x 1178-2390 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2020 |g day:01 |g pages:79-83 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/JMDH.S236275 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2020 |b 01 |h 79-83 |